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Abstract Spinocerebellar ataxia type 6 (SCA6) is a common cause of 
dominantly inherited ataxia due to an expansion of the CAG repeat in the CACNA1A 
gene. Affected individuals from the same population share a common haplotype, 
raising the possibility that most SCA6 cases have descended from a small number of 
common founders across the globe. To test this hypothesis we carried out haplotype 
analysis on SCA6 families from Europe, South America and the Far East, including 
an established de novo SCA6 expansion. A core CACNA1A disease haplotype was 
found in affected individuals across the globe. This was also present in the unaffected 
father of the de novo case, suggesting that the shared chromosome predisposes to the 
CAG repeat expansion at the SCA6 locus. The SCA6 expansion lies within a CpG 
island which could act as a cis-acting element predisposing to repeat expansion as for 
other CAG/CTG repeat diseases. Polymorphic variation in this region may explain the 
high-risk haplotype found in SCA6 families. 
 
Introduction  
Spinocerebellar ataxia type 6 (SCA6, MIM 183086) is a late onset, slowly progressive 
neurodegenerative disorder that characteristically presents with dysarthria, gait and 
limb ataxia1 and is due to an expansion of the CAG repeat in the α1A subunit of the 
voltage-dependant calcium channel gene CACNA1A.2 SCA6 appears to be an 
increasing cause of dominantly inherited ataxia, affecting at least 1.59/100,000 of the 
UK population3 and accounting for between 6 and 32% of families with autosomal 
dominant ataxia.4 Haplotype analysis in different geographical regions identified 
shared regions of chromosome 19p13 in affected individuals, suggestive of a common 
founder chromosome present in Germany,4 Japan,5,6 the Netherlands,7 and the United 
Kingdom.3 This raises the possibility that all affected individuals inherited one or a 
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few common founder chromosomes, as has been described for nucleotide repeat 
disorders.8-11 Against this hypothesis, a few proven de novo SCA6 CAG expansions 
have been described,12,13  pointing towards a predisposing chromosome, rather than a 
founder effect. We previously identified a common CACNA1A haplotype present in 
16 pedigrees with SCA6 from the north east of England.3 To determine whether this 
haplotype was due to a founder effect, or was predisposing to CAG repeat expansion 
in CACNA1A, we carried out microsatellite analysis on SCA6 families throughout the 
world, including a de novo case. 
 
Materials and methods 
 
Subjects 
 
Haplotype analysis was carried out on 96 individuals (95 affected and 1 unaffected) 
from 45 families with a molecular diagnosis of SCA6. 22 families were from the 
North East of England (n = 37 subjects, 16 of these families have been described 
before3), 12 families were Japanese (n = 31 subjects), 2 families were Brazilian (n = 7 
subjects), 2 families were Finnish (n = 2 subjects), and 9 families were Taiwanese (n 
= 18 subjects). Allele frequencies were determined in control subjects from 
corresponding geographical regions: (north of England, n = 50; Japan, n = 100; Brazil, 
n = 50; Taiwan, n = 56).  
 
Genetic analysis 
 
All samples were genotyped for the following (CA)n  microsatellite markers in the 
same laboratory: D19S912, D19S906, D19S221, D19S914, D19S1150, D19S840, 
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D19S226, D19S899 and D19S414 (primer sequences and map positions were 
obtained from the NCBI UniSTS database, Fig. 1, Supplementary table 1 on-line). 
Primers were 5’ fluorescent labeled and PCR products for each allele were 
simultaneously analysed on a single capillary DNA analyzer (Beckman CEQ 8000). 
Reaction conditions: 0.25pM of each primer, 1 U of Promega or HotMaster™ Taq 
DNA polymerase with 1x associated buffer, 2mM dNTPs and 250ng of DNA. 
Amplification was carried out at 94°C for 4min, (or 94°C for 2 min for HotMaster™), 
followed by 30 cycles of 94°C for 1 min, annealing temperature for specific 
microsatellite for 1 min and 72°C for 1 min with a final extension of 72°C for 10 min.   
 
Statistical analysis 
 
Haplotypes were constructed manually for the familial samples, and inferred using 
Phase v2.1.1 for the control subjects.14 The frequency of individual alleles and 
haplotypes in cases and controls were compared using Fishers exact test. Linkage 
disequilibrium (LD) was estimated by the parameter δ, which is an approximation of 
the population attributable risk according to the equation, δ = (Fd – Fc)/(1- Fc), where 
Fd is the frequency of the allele in carrier chromosomes and Fc is the frequency of the 
allele in non-carrier chromosomes.15 
 
Results 
Affected individuals from the six additional English families shared microsatellites 
with the sixteen families previously reported (Fig 2a), with highly significant 
association and linkage disequilibrium (LD) between the intragenic marker D19S1150, 
and flanking marker D19S840 (Table 1 and Supplementary table 2 and 3 on-line). A 
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similar haplotype was also found in the Japanese, Brazilian and Finnish SCA6 
families (Figs. 2b, 2c & 2d). Shared flanking markers between the SCA6 families 
suggest minor differences in the core haplotype (D19S1150 and D19S840) between 
these regions probably arise through single mutation events which occur between 0 to 
7 x 10-3 per locus, per gamete, per generation.16 Again, specific alleles and haplotypes 
in each population were associated and in LD with mutated CACNA1A alleles (Tables 
1 and 2, Supplementary tables 2 and 3 on-line). The same centromeric marker alleles 
were also found in the Taiwanese, as were the same telomeric alleles for D19S914 / 
D19S906 (Fig. 2e). Given that the same D19S914 alleles were strongly associated and 
in LD with mutated SCA6 alleles in both the Taiwanese and Japanese (Table 1), this 
suggests that the different intragenic D19S1150 alleles in Taiwan are also due to 
mutation of the microsatellite, as described for other intragenic diallelic markers 
defining an ancient founder haplotype which has spread throughout the world.17  
Haplotype analysis of a Japanese de novo SCA6 patient and his parents was also 
carried out. Although CAG20 alleles have been associated with late-onset mild ataxia18 
the patient was previously reported as being de novo by Shimazaki et al12, given that 
the parents were neurologically and radiologically normal at the time of the original 
study, and on follow up prior to this study (Fig. 3). The extended haplotype suggested 
that the CAG expansion occurred during paternal transmission of the CAG20 allele, 
which is characteristic of CAG repeat disorders.19 Although the core haplotype 
carrying the mutated SCA6 allele in this family is rare [D19S914(90)-
D19S1150(160)-D19S840(208)] (Supplementary table 3 on line), both telomeric 
[D19S914(90) and D19S1150(160)] centromeric to D19S840 markers that define the 
SCA6 chromosome in this family were also found in other Japanese families 
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(Supplementary table 2 on line). Thus, although it is possible that the father will go on 
to develop a mild-form of SCA6 late in life (and thus have a pathogenic allele), the 
haplotype analysis described here indicates that the unstable paternal chromosome is 
the likely origin of the de novo expansion, and that this occurred on a haplotype found 
in other Japanese SCA families. 
 
Discussion 
The identification of a common CACNA1A haplotype in affected individuals with 
SCA6 from Europe, Brazil and Japan supports the hypothesis that all SCA6 patients 
descend from a small pool of founder individuals. However, the demonstration a de 
novo SCA6 expansion on a similar genetic background raises the possibility of a 
predisposing haplotype leading to new mutation events in different populations across 
the globe. Recent evidence from SCA7 transgenic mice has shown that cis acting 
elements 3’ to the repeat drive instability of the (CAG)n at the SCA7 locus20 and a 
similar mechanism may operate for SCA6. Mice generally require a larger (CAG)n  
tract than humans to show instability of repeat lengths21,22  but introducing large 
regions of flanking human sequence allows instability for moderate repeat lengths in 
some mouse models.20,21  
CpG methylation may also influence trinucleotide repeat tract stability through an 
effect on chromosomal structure.24,25 We therefore used a bioinformatic approach 
using a previously described method used study GC content flanking other 
trinucleotide repeat genes.26,27 Genomic sequence for 5000 bp upstream, and 5000 bp 
Craig et al. Page 7 
downstream of the CACNA1A (CAG)n repeat sequence were downloaded from NCBI 
and analyzed using cpgplot (available through EMBOS) in the 5’ to 3’ orientation, 
with a moving window of 500 bp and a step of 100bp.27 This revealed a large CpG 
island immediately upstream of the CACNA1A (CAG)n repeat sequence (Fig. 4, 56bp 
upstream of the CAG repeat spanning 611 bp). These sequence characteristics are 
associated with repeat instability in other disorders.26 At 77.94%, the percentage GC 
content of the chromosomal region immediately upstream of the CACNA1A (CAG)n 
repeat is greater than that found for other unstable pathogenic repeat sequences 
(including HD, SCA1 and SCA3) and just less than the region flanking the highly 
unstable SCA7 at 83.5%.26  
It is intriguing that the region 5’ to the CAG repeat in the de novo expansion (Fig. 3) 
was defined by markers strongly associated with other mutated SCA6 alleles (Table 
1). Conversely, the region 3’ to the CAG repeat on the newly mutated chromosome 
contained alleles not associated with (CAG)n expansions (Table 1). This is in keeping 
with a common telomeric region predisposing to pathogenic repeat formation. CpG. 
Mammalian CpG islands are known sites for the initiation of transcription and may 
also act as origins of replication28 and modification of repeat instability has been 
linked to both transcription and replication origin events.29 Methylation of CpG 
islands appears to stabilize GCG tracts in fragile X syndrome,30 although the 
mechanisms involved are likely to be complex,19 and may relate to GC content and 
chromatin structure.25 It is therefore possible that sequence variation within the CpG 
island immediately upstream of the (CAG)n alters the susceptibility of specific 
CACNA1A haplotypes to cause repeat expansion, as had been described for other 
repeat sequences.31 Identifying the underlying molecular mechanism will have 
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important implications for our understanding of the onset and genetic anticipation of 
SCA6 in large dominant families.   
Supplementary information is available at http://www.nature.com/ejhg/index.html.  
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Titles and legends to figures 
CACNA1A
D19S1150D19S914
D19S221
D19S906D19S912 D19S840
D19S226
D19S899 D19S414
4Mb 786Kbp 229Kbp 792Kbp 2.6Mb 19.5Mb
Figure 1
Telomeric region Centromeric region
(CAG)n
Ch19
 
Figure 1. Schematic representation of microsatellite marker positions on chromosome 19. Black box = CACNA1A. (Mb = megabase, Kbp = 
kilobase pairs). Black box = CACNA1A. 
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183/181112/122245/239204/20621160/15490/92208/200158/170178/188B 22
181/179112/114247/249214/21621160/15490/92204/208160176/188B 21
163/181112/108245/235204/2162290/88206/208158176/188B 20
163/183112247/235204/21622160/14890/94206160/166176/188B 19
163112/114245/235212/21422160/15290/88204/206160/166176/192B 18
163114235/233212/21421160/16690/88204/206160/158180/168B 17
163/181112/106235/241204/2062116090/86204/206160/162178B 16
181/185114/106237/255202/2122316290/92206/208160/168178B 15
181/185114/106235204/2142116090/88204/206160168/192B 14
165/183110/120245/235206/21421160/16290/88198/208158/160176B 13
183/181106/128245/251206/20221160/15490/94198/196158/160176/188B 12
183/185106245/235206/21221160/16490/92198/196160/154178/176B 11
163106235/2412142216090/88206160188/190B 10.2
183/181106/108245/2352062190198160188/180B 8.1
183/17710623720622160/15490198160176/188B 7.3
1811062352062116290198160176/188B 7.2
1811062352062116290198160176/188B 7.1
163106245/2352062116290/92204164188B 6.2
163106245/2352062116290/92204164176/192B 6.1
179112245206/2162216090/92200/204158/160176/188B 5.3
179112245206/2162116090/92200/204 158/160188/186B 5.2
179112245206/2162216090/92200/204158/160188/186B 5.1
1651122452042216492204160188B 4.3
1651122452042216492204160178/176B 4.2
1651122452042216492204160188B 4.1
165114/1042452042316492208/206158/160178B 3.3
165114/1042452042316492208/206158/160178B 3.2
181/185114/1042452042216492208/206158/160178B 3.1
18311223520421162/16490/88208158178B 2.2
18311223520422162/16490/88208158178B 2.1
165112247204/21621160/16290/88208160178B 1.2
165112247206/21621160/16290/94208160178B 1.1
D19S414D19S899D19S226D19S840(CAG)nD19S1150D19S914D19S221D19S906D19S912Case
163106235/2412142216090/88206158188/190B 10.1
181106247204/2162116090206160176/184B 9.3
179/177106247204/2162216090206160176/160B 9.2
181106247204/2162116090206160178/186B 9.1
183/181106/108245/23520621160/15890200160190/182B 8.2
Figure 2a
a
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1631062332142315890/92198158176J 12.4
1631062332142315890/92198158178J 12.3
1631062332142315890/92198158178J 12. 2
163/188114/122233/237206/20423158/16890198156178J 11.1
163108/1222372022215890198156178J 10.2
163108/1222372022115890198156178J 10.1
1831222452042215890188/210156176/186J 9.4
1831222452042215890188/210156176/186J 9.3
1831222452042215890188/210156176/186J 9.2
D19S414D19S899D19S226D19S840(CAG)nD19S1150D19S914D19S221D19S906D19S912Microsatellite markers
Patient id
163114/108245/243208/21426158/16090/92196/200158178/180J 13.3
163108/106245/243200/21421158/16690/92196/188158178/180J 13.2
163/189112/114245/241208/21620158/16090/92198/200158178/180J 13.1
1631062332142315890/92198158178J 12.1
183/188114/122245/233206/21623158/16490198156178J 11.3
163114/122245/237204/21623164/16890198156178J 11.2
1831222452042215890188/210156176/186J 9.1
163/183122/126245/2472062215890/88198158176/182J 8.2
163/183122/126245/2472062215890/88198158176/182J 8.1
181/183108/122245204/21422158/15090/88198/200158/156178/176J 7.2
181/183108/122245204/21423158/15090/88198/200158/156178/176J 7.1
163122/126245/249204/20222160/16892/88198/200156/160178/176J 6.2
163122/126245/249204/20222160/16892/88198/200156/160178/176J 6.1
183112/1102452042316092198/210158178/186J 5.2
183112/1102452042316092198/210158178/186J 5.1
163/183112243/2492062015890198/200158176J 4.3
163/1831122412062015890198/200158176J 4.2
163/1831122412062015890198/200158176J 4.1
163/189112/11024120421158/15690/92198/202158190/182J 3.2
163/189112/11024120421158/15690/92198/202158190/182J 3.1
163/183106241204/21422158/15490/88202160186J 2.2
163/183106241204/21422158/15490/88206160186J 2.1
163/1901142472042215890206158178/176J 1.3
163/1831142472042215890206158178/176J 1.2
183/1881142472042115890206158178/ 176J 1.1
Figure 2b
b
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183/1871122452062516294196160188Br  2.2
181/1871122452062616294196160188Br 2.1
1791122452062516294196/204160188Br 1.4
179112233/2512062516294196/204160188Br 1.3
179112233/2512062516294196/204160188Br 1.2
179112233/2512062616294196/204160188Br 1.1
D19S414D19S899D19S226D19S840(CAG)nD19S1150D19S914D19S221D19S906D19S912Microsatellite
Markers
Patient id
163114/104235/237206/21022162/15490/88198/206176/168F 2
163104/102235/237206/21022160/16290/88206/204176F 1
D19S414D19S899D19S226D19S840(CAG)nD19S1150D19S914D19S221D19S906D19S912Microsatellite
Markers
Patient id
c
163110/114245206/2142316090/86206158/162178T 9.1
163110/114245206/2142316090/86206158/162178T 9.2
163/183122241206/2142316890/92200162/164178T 8.2
163/183122241206/2142316890/92200162/164178T 8.1
183124251206/2142316890/88178156180T 7.2
183124251206/2142316890/88178156180T 7.1
1631222512042316890/92196158180/186T 6.2
1631222512042316890/92196158180/186T 6.1
163120241/2512042216890/92196158180T 5.2
163120241/2512042216890/92196158180T 5.1
1631142472042516892/88196/178158182T 4.2
1631142472042516892/88196/178158182T 4.1
1631122472042116892196/194158178T 3.2
1631122472042116892196/194158178T 3.1
1631102392042316892196/200158188T 2.2
1631102392042316892196/200158188T 2.1
163/181110241/2392042316892198/196158178T 1.2
163/181110241/2392042316892198/196158178T 1.1
D19S414D19S899D19S226D19S840(CAG)nD19S1150D19S914D19S221D19S906D19S912Microsatellite markers
Patient id
Figure 2c-e
d
e
 
Figure 2. CACNA1A haplotypes for the SCA6 subjects. (a) British, (b) Japanese (c) Brazilian, (d) Finnish, and (e) Taiwanese SCA6 patients. 
Numbers after the decimal place represent individuals within a family. Haplotypes were determined manually. Both alleles are shown where it 
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was not possible to determine phase. Shared alleles are color coded in dark green. The most common (core) haplotype is shown in dark green, 
with paler shading slightly different haplotypes which are closely related to the core haplotype (differing by one or two di-nucleotide repeats) 
and probably differ due to microsatellite instability. Unshaded regions are regions that differ through recombination and are not related to the 
core haplotype. 
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Figure 3 Pedigree for the de novo SCA6 patient and their parents showing the haplotypes and the possible inherited haplotype from parent to 
offspring.  
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Figure 4. Bioinformatic analysis of the 5000bp of DNA sequence flanking either side of the CACNA1A (CAG)n repeat, based on the algorithm 
of Gardiner-Gardiner and Frommer (1987). Upper panel: CpG prediction plots (observed/expected). Middle panel: percentage CG residues 
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(%CG). Lower panel: predicted CpG islands. The (CAG)n repeat is indicated by an open arrow. Note that the numbering left to right corresponds 
reflects the direction of the NCBI chromosomal sequence. The gene is transcribed from right to left (solid arrow).  
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Tables 
Table 1.  Frequency of microsatellite marker alleles in SCA6 families and control subjects from the same geographic region. p-values 
were calculated using Fisher’s exact test. The parameter δ is an approximation of the population attributable risk according to the equation, δ = 
(Fd – Fc)/(1- Fc), where Fd is the frequency of the allele in carrier chromosomes and Fc is the frequency of the allele in non-carrier chromosomes. 
Control subjects were from the same geographic region (see text) 
Only significant associations are shown in this table. The entire data set is shown in supplementary table 2 on-line. 
 
Frequency Ethnic 
origin 
Marker  / allele  
Controls SCA6 
families 
Fisher’s 
exact (p) 
δ 
British D19S1150 154 0.34 0.13 0.0021 0.42 
 D19S1150 160 0.19 0.41 0.0018 0.16 
 D19S1150 164 0.02 0.13 0.0082 0.32 
 D19S840 216 0.01 0.16 0.0002 0.153 
Japanese D19S914 88 0.1 0.22 0.0114 0.138 
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 D19S914 90 0.69 0.46 0.0008 -0.738 
 D19S914 92 0.12 0.25 0.0183 0.147 
 D19S1150 158 0.17 0.47 0.0001 0.359 
 D19S1150 160 0.28 0.15 0.0332 -0.186 
 D19S1150 166 0.22 0.03 0.0001 -0.252 
 D19S1150 168 0.02 0.09 0.0207 0.069 
 D19S840 202 0.03 0.12 0.0099 0.09 
Brazilian D19S914 94 0.07 0.5 0.0005 0.462 
 D19S840 206 0.25 0.58 0.0363 0.444 
 D19S840 218 0 0.25 0.001 0.25 
Taiwanese D19S914 90 0.6 0.36 0.019 -0.597 
 D19S914 92 0.11 0.39 0.0007 0.313 
 D19S1150 166 0.32 0 0.0001 -0.464 
 D19S1150 168 0.05 0.56 0.0001 0.533 
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Table 2 Frequency of CACNA1A haplotypes in SCA6 families and controls defined by microsatellite markers D19S914, D19S1150 and 
D19S840. p-values were calculated using Fisher’s exact test. The parameter δ is an approximation of the population attributable risk according to 
the equation, δ = (Fd – Fc)/(1- Fc), where Fd is the frequency of the allele in carrier chromosomes and Fc is the frequency of the allele in non-
carrier chromosomes. Control subjects were from the same geographic region (see text). Only significant associations are shown in this table. 
The entire data set is shown in supplementary table 3 on-line.  
 
Frequency 
Ethnic 
origin 
CACNA1A 
haplotype 
Controls SCA6 
families 
Fisher’s 
exact (p) 
δ 
British 90/154/204 0.1 0 0.0054 -0.111 
 90/162/206 0.03 0.42 0.0001 0.441 
 92/160/206 0 0.20 0.0001 0.203 
 92/160/214 0 0.05 0.0312 0.054 
 92/162/206 0.01 0.09 0.0110 0.085 
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 92/164/204 0 0.05 0.0312 0.054 
Japanese 88/154/214 0 0.04 0.0158 0.044 
 90/158/204 0 0.14 0.0001 0.147 
 90/158/214 0 0.15 0.0001 0.147 
 90/158/206 0 0.09 0.0001 0.103 
 90/160/204 0.56 0.01 0.0001 -1.214 
 90/160/206 0.07 0 0.0240 -0.0752 
 90/166/204 0.17 0 0.0001 -0.2048 
 92/156/204 0 0.04 0.0158 0.044 
 92/168/204 0 0.04 0.0158 0.044 
Brazilian 90/154/218 0 0.25 0.001 0.25 
 92/160/204 0.47 0 0.0012 -0.887 
 94/162/206 0 0.5 0.0001 0.5 
 96/160/204 0.49 0 0.001 -0.961 
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Taiwanese 88/152/210 0.44 0 0.0001 -0.778 
 90/154/208 0.49 0 0.0001 -0.965 
 90/160/214 0 0.14 0.0007 0.139 
 92/168/204 0 0.31 0.0001 0.305 
 
 
 
  
 
 
 
